Gillis is managing director of Arch Venture Partners and was founder and CEO of Corixa before it was acquired by GlaxoSmithKline.    From Wordnik.com.  [in-PharmaTechnologist RSS] Reference

In the louse, the embryo, late in its life, resembles the embryos of other insects, even Corixa, a member of a not remotely allied family.    From Wordnik.com.  [Our Common Insects A Popular Account of the Insects of Our Fields, Forests, Gardens and Houses] Reference

Theraclone is led by Steven Gillis, a scientist and venture capitalist who previously co-founded the biotechnology companies Immunex and Corixa.    From Wordnik.com.  [NYT > Home Page] Reference

Theraclone, based in Seattle, is headed by Steven Gillis, who co-founded the biotechnology companies Immunex and Corixa, the newspaper reported.    From Wordnik.com.  [Pfizer, Theraclone to Collaborate on Antibody Drugs, NYT Reports - Bloomberg] Reference

The firm's investments in life sciences include: ArthroCare (ARTC), Aspreva Pharmaceuticals Corporation (ASPV, acquired by Galenica group, SWX: GALN), Cor Therapeutics (CORR; acquired by Millennium Pharmaceuticals, MLNM), Corixa (CRXA; acquired by GlaxoSmithKline, GSK), Coulter Pharmaceutical (CLTR; acquired by Corixa Pharmaceuticals, CRXA), Cubist Pharmaceuticals.    From Wordnik.com.  [BioSpace.com Featured News and Stories] Reference

The firm's investments in life sciences include: ArthroCare, Aspreva Pharmaceuticals Corporation (acquired by Galenica group), Cor Therapeutics (acquired by Millennium Pharmaceuticals), Corixa (acquired by GlaxoSmithKlein), Coulter Pharmaceutical (acquired by Corixa Pharmaceuticals), Cubist Pharmaceuticals, Epicor Medical (acquired by St. Jude Medical), Inspire Pharmaceuticals, IntraLase, Myogen, Spinal Dynamics (acquired by Medtronic).    From Wordnik.com.  [Marketwire - Breaking News Releases] Reference